As Canada-US trade-war draws nigh, so does the threat to nationalise US pharma patents
by from on (#3Z6NA)
Last June, U of Ottawa law professor/biomedical scientist Amir Attaran floated the idea of invalidating US pharma patents as a way for Canada to retaliate against trade attacks by the Trump administration. (more")